All correspondence regarding a manuscript must be conducted through the designated corresponding author, who is required to provide a valid institutional email address. Submissions without this requirement will not be processed for peer review or publication.

Submission Components

1. Cover Letter

A cover letter is mandatory for all submissions. It should briefly explain the relevance of the article to the scope of the journal and highlight how the work contributes to advancing oncology research and practice.

2. Title Page

The title page must include:

• Full names, academic titles, and institutional affiliations of all authors.
• Contact details of the corresponding author, including a verified email address.
• ORCID iD for each author to ensure accurate identification of their scholarly contributions.
• A complete title (maximum 150 characters) and a short running title (maximum 60 characters).
• Five to ten keywords for indexing purposes, avoiding words already used in the title.

3. Abstract

The abstract should not exceed 300 words. It must be structured under the following headings (as applicable):

• Background/Objectives
• Materials and Methods (or Case Presentation for case reports)
• Results
• Conclusions

Narrative reviews do not require a structured abstract. Editorials and Letters to the Editor do not require an abstract.

4. Main Text, Tables, and Figures

The main text should be clearly organized, concise, and supported by appropriately formatted tables and figures. Each table and figure must be cited within the manuscript and include a descriptive title or legend.

5. References

References should be numbered consecutively in the order they appear in the text. Superscript Arabic numerals should be used without parentheses.

Document File Formats for Submission

Manuscripts must be submitted as a single Microsoft Word file (.doc or .docx) containing all required sections, excluding figure files. Pages should be numbered consecutively using Arabic numerals at the bottom of each page. In addition, authors are required to include continuous line numbering throughout the manuscript to facilitate the peer review process and any subsequent revisions.

Submission Checklist for Authors

Before sending a manuscript to the European Journal of Oncology, authors should verify that their submission includes all required components:

• Cover Letter
• Copyright Transfer Agreement
• Title Page (full title, running head, author names, affiliations, email addresses, and corresponding author details with ORCID iD (optional))
• Abstract
• Keywords
• Main Text
• References
• Figures (with figure legends)
• Tables (with table legends)
• Final Declarations (conflict of interest, funding, acknowledgments, ethical approval, where applicable)

References

References must be provided at the end of the manuscript and listed in numerical order according to their first appearance in the text. Reference citations in the text must be indicated with superscript Arabic numerals, without parentheses.

When citing multiple references:

• Two separate references (e.g., “1,2”) must be separated by a comma.
• Three or more consecutive references should be written as a range (e.g., “1-6”).

All listed references must include the full names of all authors (do not use et al.), the year of publication (without month), the journal name, volume number, and page range. The issue number should not be included.

Correct:
Smith J, Ahmed R, Chen L, Martinez P, Rossi G. Targeted therapies and clinical outcomes in advanced lung carcinoma. Eur J Oncol 2022; 18: 1128-6598.

Incorrect:
Smith J, Ahmed R, Chen L, Martinez P, Rossi G. Targeted therapies and clinical outcomes in advanced lung carcinoma. EurJOncol 2022;18:1128-6598.

The European Journal of Oncology does not accept references such as “data not shown” or “unpublished data.” Papers accepted for publication but not yet available should be cited as “in press” or “forthcoming.”

Declarations and Final Statements

Conflict of Interest

Authors are required to disclose any financial or personal relationships with individuals or organizations that could inappropriately influence (bias) their work. Examples include consultancies, employment, stock ownership, honoraria, paid expert testimony, patent applications or registrations, and grants or other funding.

Examples of disclosure statements:

• [Author Name] has served as a speaker, consultant, and advisory board member for [Organization Name] and has received research funding from [Organization Name].
• [Author Name] is an employee of [Organization Name].
• [Author Name] owns stocks or shares in [Organization Name].
• [Author Name] is the inventor of patent [Patent ID, brief description].

If no potential conflicts exist, the following statement must be included:
“The authors declare that they have no conflict of interest to disclose.”

Funding

Authors must acknowledge all sources of financial support for the research. This should include the name of the funding body, grant numbers (where applicable), and any funding interests.

Authors’ Contributions

In the interest of transparency, a description of each author’s contribution must be provided in accordance with the CRediT (Contributor Roles Taxonomy) system.

Example format:

• [Author 1]: Conceptualization, Methodology, Writing – Original Draft Preparation.
• [Author 2]: Data Curation, Formal Analysis, Writing – Review & Editing.
• [Author 3]: Supervision, Funding Acquisition, Project Administration.

Data Availability Statement

Authors must include a statement on the availability of data used in the study. Acceptable formats include (but are not limited to):

• The datasets generated and/or analyzed during the current study are available in [Repository Name] at [Permanent Web Link].
• The datasets generated and/or analyzed during the current study are not publicly available due to [Reason], but are available from the corresponding author upon reasonable request.
• Data sharing is not applicable as no datasets were generated or analyzed during this study.
• All data generated or analyzed during this study are included in this published article [and/or its supplementary files].

Copyright Transfer Agreement

For all manuscripts accepted for publication in the European Journal of Oncology, authors are required to complete and sign a Copyright Transfer Agreement (CTA). The signed CTA is a mandatory condition of publication; manuscripts will not proceed to production until the editorial office has received the completed form.

Once submitted to the European Journal of Oncology, manuscripts may not be sent to other journals. Upon acceptance, copyright for the article is transferred to the Publisher, while authors retain the right to use their work for academic, teaching, and non-commercial purposes with proper citation of the original publication.

The corresponding author will receive the appropriate CTA form from the editorial office. The completed and signed form must be returned either by email to [insert official journal email address] or uploaded directly through the online submission system at the time of manuscript submission.

The Editors reserve the right to make editorial adjustments to style and format. Substantial changes, if necessary, will be discussed with the corresponding author. The final decision on the timing of publication remains with the Editors.

Third-Party Permission and Trademarks

Authors are responsible for ensuring that their manuscripts do not include material protected by copyright unless proper authorization has been obtained. Any use of copyrighted third-party content—defined as material not originally created by the author(s)—requires written permission from the copyright holder, typically the original publisher.

Third-party content may include, but is not limited to: figures, photographs, illustrations, charts, tables, equipment or tool images, and material reproduced from websites, books, journal articles, theses, reports, or conference proceedings.

Documentation verifying permission to use such content must be obtained prior to submission and forwarded to the editorial office at editor@ejoncology.it for archiving. Authors should retain copies of all permissions for their records.

The use of proprietary names, trademarks, or brand names must be clearly identified with an initial capital letter and accompanied by the appropriate acknowledgment of ownership.

How to Submit Your Manuscript

Manuscripts should be submitted through the Online Submission Form Submit Here or directly via email to the editorial office at submit@ejoncology.it. Authors are advised to ensure that all required components, as outlined in the Authors’ Guidelines, are included before submission.